Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Grifols ‘continues global expansion’

Grifols ‘continues global expansion’

3rd March 2009

Grifols has continued its global expansion with the acquisition of a Swiss and Australian group.

The company explains a transaction worth 25 million euros (22.42 million pounds) was undertaken through a capital increase in the body.

Grifols now owns 49 per cent of the capital stock in the group, as well as gaining full control.

A holding company with three differentiated areas of activity will serve as a medium for the transaction.

Ramon Riera, commercial vice-president of Grifols, states: "With the establishment of a presence in the US – and after having significantly enhanced the production of biological products – the company is now focusing on increasing its market share in the countries of Latin America.

Asia – specifically China – is also a target for the company, he added, stating the firm needs to wait until it has a sufficient market share in the USA and for production to be increased before it can move forwards.

In recent days, Grifols announced registration has officially opened for participation in the 2009 Martin Villar Haemostasis Awards.ADNFCR-1050-ID-19055516-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.